Company Overview and News

 
Insurer Anthem will pay record $16M for massive data breach

3h nzherald.co.nz
WASHINGTON (AP) — The nation's second-largest health insurer has agreed to pay the government a record $16 million to settle potential privacy violations in the biggest known health care hack in U.S. history, officials said Monday.
ATHTF ANTM ANTX

 
Should Value Investors Buy Anthem (ANTM) Stock?

2018-10-12 zacks
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
ANTM

70
Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Facebook, GE, 3M, Microsoft, Netflix, Snap, Square, Twitter and More

2018-10-12 247wallst
Stocks were indicated higher on Friday as overseas markets stabilized, but this is following sharp selling pressure this week in the major U.S. equity indexes. While the all-time highs are still within striking distance, investors have seen lower upside from buying immediately after the big market pullbacks in 2018 than in prior years. Now those investors also have to consider how to position their investments for the rest of the year and into 2019.
ATHTF FB FIT MTSI NFLX AMZN TWTR MS MMM GE GEC CARB ANTM BABA TRI GNE MSFT ANTX

 
The Zacks Analyst Blog Highlights: Ameren, Pattern Energy, Algonquin, Sysco and Anthem

2018-10-12 zacks
Chicago, IL –October 12, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ameren Corp. (AEE - Free Report) , Pattern Energy Group Inc. (PEGI - Free Report) , Algonquin Power & Utilities Corp. (AQN - Free Report) , Sysco Corp.
SYY AEE PEGI STLD PEG ANTM LB OUT AQN

 
5 Ultra-Safe Stocks That Will Endure the Wall Street Bloodbath

2018-10-12 investorplace
The stock market freefall continues in October, as investors remain worried about interest rates rising from historic low levels. The recent rise in benchmark bond yield has marred the appeal of stocks, especially with valuations near historically high levels.
SYY AEE PEGI PEG ANTM AQN

 
5 Ultra-Safe Stocks to Survive the Wall Street Bloodbath

2018-10-11 zacks
The stock market freefall continues in October, as investors remain worried about interest rates rising from historic low levels. The recent rise in benchmark bond yield has marred the appeal of stocks, especially with valuations near historically high levels.
SYY AEE PEGI PEG ANTM AQN

16
UPDATE 3-CVS, Aetna win U.S. approval for $69 bln deal

2018-10-10 reuters
WASHINGTON/NEW YORK (Reuters) - Pharmacy chain CVS Health Corp (CVS.N) won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc (AET.N), the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers.
ATHTF WCG ANTM CI CVS HUM AET ANTX

19
CVS, Aetna win US approval for US$69 billion deal

2018-10-10 channelnewsasia
The U.S. Justice Department is expected to approve drug retailer CVS Health Corp's deal to buy health insurer Aetna Inc as soon as Wednesday, a source familiar with the review said.
ATHTF BRK.A WCG ANTM CI CVS HUM AET ANTX

4
WellCare Health, agilon health to Provide Value-Based Care

2018-10-09 zacks
WellCare Health Plans, Inc. (WCG - Free Report) has announced that it is expanding its providers’ network through a value-based care agreement with leading national organization, agilon health. With this deal, WellCare Health will offer an excellent operating platform to patients by giving them access to primary care physicians. The transaction is aimed at providing improved treatment to patients in Texas.
UAM WCG ANTM HUM UNH UAMCP

26
Community Health Divests Unit to Focus on Core Business

2018-10-04 zacks - 1
Community Health Systems, Inc. (CYH - Free Report) recently announced that it has completed its pending divestiture of the 238-bed AllianceHealth Deaconess hospital in Oklahoma City, OK and its related businesses to a unit of INTEGRIS Health. The sale also consists of physician clinic operations and outpatient services. The effective date of the transaction is Oct 1, 2018. The company’s affiliates continue to operate seven hospitals in Oklahoma.
LMT CYH MOH RNVAZ RNVA WCG CYHHZ ANTM UTX RNVAW

 
Can Anthem (ANTM) Keep the Earnings Surprise Streak Alive?

2018-10-03 zacks
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Anthem (ANTM - Free Report) , which belongs to the Zacks Medical - HMOs industry, could be a great candidate to consider.
EMN ANTM

25
Community Health's (CYH) Ratings Downgraded, Outlook Stable

2018-09-28 zacks
Credit rating giant Moody's Investors Service ("Moody's") recently downgraded the Corporate Family Rating (CFR) of Community Health Systems, Inc. (CYH - Free Report) from Caa2 to Caa3 and the Probability of Default Rating from Caa2-PD to Caa3-PD. The agency has further downgraded the first lien senior secured debt to Caa1 from B3, the junior lien debt to Ca from Caa3, the unsecured debt to C from Ca and the Speculative Grade Liquidity Rating to SGL-4 from SGL-3.
CYH MOH CBT WCG CYHHZ ANTM RPM

10
4 Health Insurance Stocks Poised for Earnings Beat in Q3

2018-09-28 zacks
The health insurance industry delivered a stellar operating performance in the first six months of 2018 with most players reporting an improving top and the bottom line.
GPN CI ANTM HUM UNH

 
Is Anthem (ANTM) Stock Outpacing Its Medical Peers This Year?

2018-09-27 zacks
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Anthem (ANTM - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
ANTM

3
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio (revised)

2018-09-26 zacks
Estimates for UnitedHealth Group Inc. (UNH - Free Report) have been revised upward over the past seven days, reflecting analysts' optimism on the stock. The stock has seen the Zacks Consensus Estimate for 2019 earnings move 0.1 % north over the same time frame. Shares of this Zacks Rank #2 (Buy) company have surged nearly 35.5% in the past year, underperforming the industry’s growth of 36.8%.
MOH GTS ANTM UNH

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ANTM / Anthem, Inc. on message board site Silicon Investor.

ANTM Antennas America ANTM Antennas America ANTM Antennas America
CUSIP: 036752103